Ociperlimab (Anti-TIGIT) | Immunology & Inflammation related antibody

Ociperlimab (anti-TIGIT) is a humanized immunoglobulin G1 (IgG1) monoclonal antibody targeting the co-inhibitory molecule and immune checkpoint inhibitor T-cell immunoreceptor with immunoglobulin (Ig) and immunoreceptor tyrosine-based inhibitory motif (ITIM) domains (TIGIT), with potential immune checkpoint inhibitory activity. MW: 145.12 kD.

Purity & Quality Control

Batch: A297001 Purity: 99% Protein concentration: 11.61mg/ml Endotoxin Level: ＜1EU/mg

99

Choose Selective Immunology & Inflammation related Inhibitors

Biological Activity

Description	Ociperlimab (anti-TIGIT) is a humanized immunoglobulin G1 (IgG1) monoclonal antibody targeting the co-inhibitory molecule and immune checkpoint inhibitor T-cell immunoreceptor with immunoglobulin (Ig) and immunoreceptor tyrosine-based inhibitory motif (ITIM) domains (TIGIT), with potential immune checkpoint inhibitory activity. MW: 145.12 kD.

References
[1] Chen X, et al. Front Immunol. 2022 Feb 22;13:828319.

References

[1] Chen X, et al. Front Immunol. 2022 Feb 22;13:828319.

Product Details

CAS No.	2342597-93-5
Molecular Weight	145.12
Isotype	Human IgG1
Source	CHO
Purification	AKTA
Sterility	0.2 μM filtered
Formulation	100mMPro-Ac,20mMArg-Ac，pH5.0
Storage (From the date of receipt)	Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.

Tech Support

If you have any other enquiries, please leave a message.

* Indicates a Required Field